TrianglePUBLICATIONS · 15486066
The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2005 Feb 1
- First author
- Woessmann W
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Woessmann W
- type
- Author
- name
- Seidemann K
- type
- Author
- name
- Mann G
- type
- Author
- name
- Zimmermann M
- type
- Author
- name
- Burkhardt B
- type
- Author
- name
- Oschlies I
- type
- Author
- name
- Ludwig WD
- type
- Author
- name
- Klingebiel T
- type
- Author
- name
- Graf N
- type
- Author
- name
- Gruhn B
- type
- Author
- name
- Juergens H
- type
- Author
- name
- Niggli F
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Woessmann W
- type
- Author
- name
- Seidemann K
- type
- Author
- name
- Mann G
- type
- Author
- name
- Zimmermann M
- type
- Author
- name
- Burkhardt B
- type
- Author
- name
- Oschlies I
- type
- Author
- name
- Ludwig WD
- type
- Author
- name
- Klingebiel T
- type
- Author
- name
- Graf N
- type
- Author
- name
- Gruhn B
- type
- Author
- name
- Juergens H
- type
- Author
- name
- Niggli F
- type
- Author
- bibliography ids
- nci-bib-d7bbfb2f275fda0ce106c1e6
- book metadata
- content sha256
- 120559254476a1cdfebbdcd8e1ccd0fe5b99623cb423a788ae4077d5a6219ace
- document type
- citation
- dois
- 10.1182/blood-2004-03-0973
- electronic publication date
- display
- 2004 Oct 14
- precision
- day
- year
- 2004
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:15486066
- immutable id
- pubmed:15486066@120559254476a1cdfebbdcd8e1ccd0fe5b99623cb423a788ae4077d5a6219ace
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 3
- name
- Blood
- nlm unique id
- 7603509
- pages
- 948-58
- volume
- 105
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 15486066
- provenance
- batch id
- 97b9e848a139d5f8d462
- provider
- NCBI PubMed ESummary
- record sha256
- 814c1e90d9edb9d37fd70806a21f45488371c9f6a1c2d33c0bda78d25bb25074
- response sha256
- a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
- retrieved at
- 2026-09-09T23:45:57.930512+00:00
- publication date
- display
- 2005 Feb 1
- precision
- day
- year
- 2005
- publication types
- Clinical Trial
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95.
Preserved source evidence · Not medical advice